A federal judge on Wednesday ruled that the Food and Drug Administration’s (FDA) decision to remove popular GLP-1s from its drug shortage list, ending the sale of compounded versions of the ...

Weight-loss drugs are taking a big bite out of the food business. People taking meds like Ozempic, Mounjaro and Wegovy — originally developed to treat Type 2 diabetes — spend less on groceries ...

Pittman rejected a separate challenge in May brought by the same groups over the FDA's removal of Eli Lilly’s (LLY.N) weight loss and diabetes drugs Zepbound and Mounjaro from the shortage list.

Some of the most recognizable brand names that could be impacted by new tariffs include Ozempic and Wegovy, two injectable ...

Some consumers are taking smaller than standard doses of GLP-1s—the popular class of weight-loss and diabetes drugs that include Ozempic, Wegovy, and Zepbound—or spacing out doses longer than ...